Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-04

Clinical Trial Update: Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating erythropoietin treatment in patients with systolic left ventricular dysfunction, mild anemia, and normal renal function for he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN